Advanced search
Start date
Betweenand
Related content
(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

urvey of SARS-CoV-2 genetic diversity in two major Brazilian cities using a fast and affordable Sanger sequencing strateg

Full text
Author(s):
Show less -
Dorlass, Erick Gustavo [1] ; Lourenco, Karine Lima [2] ; Miserani Magalhaes, Rubens Daniel [2] ; Sato, Hugo [2] ; Fiorini, Alex [2] ; Peixoto, Renata [2] ; Coelho, Helena Perez [2] ; Telezynski, Bruna Larotonda [1] ; Scagion, Guilherme Pereira [1] ; Ometto, Tatiana [1] ; Thomazelli, Luciano Matsumiya [1] ; Leal Oliveira, Danielle Bruna [3] ; Fernandes, Ana Paula [2] ; Durigon, Edison Luiz [1] ; Fonseca, Flavio Guimaraes [2] ; Ribeiro Teixeira, Santuza Maria [2]
Total Authors: 16
Affiliation:
[1] Univ Sao Paulo, Sao Paulo - Brazil
[2] Univ Fed Minas Gerais, Ctr Tecnol Vacinas, Rua Prof Jose Vieira de Mendonca 770, BR-31310260 Belo Horizonte, MG - Brazil
[3] Hosp Israelita Albert Einstein, Sao Paulo - Brazil
Total Affiliations: 3
Document type: Journal article
Source: Genomics; v. 113, n. 6, p. 4109-4115, NOV 2021.
Web of Science Citations: 0
Abstract

Genetic variants of SARS-CoV-2 have been emerging and circulating in many places across the world. Rapid detection of these variants is essential since their dissemination can impact transmission rates, diagnostic procedures, disease severity, response to vaccines or patient management. Sanger sequencing has been used as the preferred approach for variant detection among circulating human immunodeficiency and measles virus genotypes. Using primers to amplify a fragment of the SARS-CoV-2 genome encoding part of the Spike protein, we showed that Sanger sequencing allowed us to rapidly detect the introduction and spread of three distinct SARSCoV-2 variants in two major Brazilian cities. In both cities, after the predominance of variants closely related to the virus first identified in China, the emergence of the P.2 variant was quickly followed by the detection of the P1 variant, which became dominant in less than one month after it was first detected. (AU)

FAPESP's process: 20/06409-1 - Evaluation of humoral immune response and inflammatory response in patients with confirmed diagnosis of COVID-19 at Hospital Sírio Libanês and correlation with disease severity
Grantee:Edison Luiz Durigon
Support Opportunities: Regular Research Grants